DocMorris AG
SWB:ZRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DocMorris AG
SWB:ZRE
|
CH |
|
N
|
NextSource Materials Inc
F:1JWA
|
CA |
|
CPI Card Group Inc
NASDAQ:PMTS
|
US |
|
C
|
Citigroup Inc
LSE:0R01
|
US |
|
P
|
Premium Group Co Ltd
OTC:PMMFF
|
JP |
|
G
|
Genesis Minerals Ltd
XBER:3G2
|
AU |
|
Beeks Financial Cloud Group PLC
LSE:BKS
|
UK |
|
Medios AG
OTC:MEDOF
|
DE |
|
W
|
WPP PLC
SWB:0WP
|
UK |
|
Mckesson Corp
NYSE:MCK
|
US |
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
Wijaya Karya Beton Tbk PT
IDX:WTON
|
ID |
|
B
|
Buckle Inc
LSE:0HQ7
|
US |
|
T
|
Tubacex SA
XBER:TCX
|
ES |
|
C
|
Cameco Corp
DUS:CJ6
|
CA |
|
Vision Inc
TSE:9416
|
JP |
|
B
|
BTB Real Estate Investment Trust
OTC:BTBIF
|
CA |
Wall St Price Targets
ZRE Price Targets Summary
DocMorris AG
According to Wall Street analysts, the average 1-year price target for
ZRE is 5.62 EUR with a low forecast of 3.539 EUR and a high forecast of 8.738 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZRE's stock price target?
Price Target
5.62
EUR
According to Wall Street analysts, the average 1-year price target for
ZRE is 5.62 EUR with a low forecast of 3.539 EUR and a high forecast of 8.738 EUR.
What is the Revenue forecast for DocMorris AG?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for DocMorris AG?
Projected CAGR
13%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 13%.